Akums Drugs and Pharmaceuticals Limited (BOM:544222)
530.60
+0.10 (0.02%)
At close: Apr 25, 2025
BOM:544222 Revenue
Akums Drugs and Pharmaceuticals had revenue of 10.10B INR in the quarter ending December 31, 2024, a decrease of -6.69%. This brings the company's revenue in the last twelve months to 40.10B, down -3.40% year-over-year. In the fiscal year ending March 31, 2024, Akums Drugs and Pharmaceuticals had annual revenue of 41.82B with 14.34% growth.
Revenue (ttm)
40.10B
Revenue Growth
-3.40%
P/S Ratio
2.08
Revenue / Employee
5.43M
Employees
7,388
Market Cap
83.51B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 41.82B | 5.24B | 14.34% |
Mar 31, 2023 | 36.57B | -180.32M | -0.49% |
Mar 31, 2022 | 36.75B | 9.49B | 34.81% |
Mar 31, 2021 | 27.26B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition